levothyroxine recall 2026

The quick read

What's driving the attention

A levothyroxine medication recall was issued by the FDA in 2026 due to concerns over subpotency affecting patients.

In 2026, the FDA issued a nationwide recall of a levothyroxine thyroid medication described as subpotent, raising concerns among patients dependent on this treatment. Levothyroxine is a critical hormone replacement therapy used to manage hypothyroidism and other thyroid conditions. Studies and expert analyses highlight challenges with correct administration and absorption, emphasizing the potential clinical impact during conditions like sepsis.